AI Insights Hubaieverywherebriefing.substack.com
Pfizer’s AI drug discovery platform identifies new oncology candidate entering Phase II trials
Pfizer announced that its AI-driven drug discovery platform has successfully identified a novel cancer treatment candidate that is now entering Phase II clinical trials, highlighting the growing use of AI in pharmaceutical R&D and oncology drug development.[2]
